Immix Biopharma, Inc.
IMMX
$10.97
$0.050.46%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -39.92M | -34.98M | -29.44M | -23.56M | -23.13M |
| Total Depreciation and Amortization | 487.20K | 436.10K | 364.50K | 315.20K | 206.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.58M | 2.17M | 2.44M | 2.58M | 2.84M |
| Change in Net Operating Assets | -1.65M | 301.80K | 2.70M | 6.29M | 7.57M |
| Cash from Operations | -38.50M | -32.07M | -23.93M | -14.38M | -12.51M |
| Capital Expenditure | -591.10K | -697.70K | -732.90K | -1.08M | -974.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.56M | -11.25M | -6.48M | -- | -- |
| Cash from Investing | -9.15M | -11.95M | -7.21M | -1.08M | -974.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 261.66M | 107.56M | 107.52M | 11.89M | 1.11M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -137.00K | -208.10K | -137.00K | -166.80K | -- |
| Cash from Financing | 261.52M | 107.35M | 107.39M | 11.72M | 1.11M |
| Foreign Exchange rate Adjustments | -20.40K | -1.00K | 3.80K | -9.60K | 34.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 213.85M | 63.33M | 76.25M | -3.74M | -12.34M |